[1]邢爽,李明,黄海潇,等.急性辐射损伤的细胞因子联合治疗研究进展[J].国际放射医学核医学杂志,2008,32(1):47-50.
 XING Shuang,LIMing,HUANG Hai-xiao,et al.Cytokines combination in acute radition injury management[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):47-50.
点击复制

急性辐射损伤的细胞因子联合治疗研究进展(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第1期
页码:
47-50
栏目:
放射生物学
出版日期:
1900-01-01

文章信息/Info

Title:
Cytokines combination in acute radition injury management
作者:
邢爽 李明 黄海潇 罗庆良
100850 北京, 军事医学科学院放射与辐射医学研究所放射病实验治疗研究室
Author(s):
XING Shuang LIMing HUANG Hai-xiao LUO Qing-liang
Department of Experimental Therapy of Radiation Sickness, Beijing Institute of Radiation Medicine, Beijing 100850, China
关键词:
辐射损伤细胞因子造血生长因子
Keywords:
Radiation injuriesCytokinesHematopoietic growth factors
分类号:
Q691;R818.05
摘要:
细胞因子对急性辐射损伤的治疗作用日益受到重视,尤其是造血生长因子抗辐射作用的研究取得了长足进展。但随着照射剂量的增加,造血干,祖细胞大量死亡及皮肤和胃肠道等非造血系统损伤加重,单一的细胞因子难以逆转严重损伤,因此细胞因子的联合应用成为必然。当前,细胞因子联合治疗急性辐射损伤的研究主要集中于造血生长因子及抗凋亡细胞因子联合应用效果的评价,结果提示,照射后早期细胞因子联合应用是事故性辐射损伤的有效治疗措施。
Abstract:
Cytokine-based treatment was well applied to manage acute radiation injury in recent years.Unfortunately, efficacy of single cytokine was reduced because of multiple organs severe injury caused by high dose irradiation. It is the rationale for cytokines combination. Anti-radiation efficacy of cytokines combination were reviewed, especially hematopoietic growth factors and antiappoptic cytokines combined in acute radiation injury management were documented. Emergency cytokines combination would be an alternative for acute radiation injury treatment.

参考文献/References:

[1] Li Z, Wenyi Z, Liang’an Z. General situation of radiation accidents in China[J]. Radiat Prot Dosimety, 2007, 124(2):177-180.
[2] Weisdorf D, ChaoN, Waselenko JK, et al. Acute radiation injury:contingency planning for triage,supportive care, and transplantation[J]. Biol Blood Marrow Transplant, 2006, 12(6):672-682.
[3] 罗庆良,从玉文,郝静,等.造血因子与急性放射病[J].解放军医学杂志,2005,30(3):186-190.
[4] Van der Meeren A, Mouthon MA, Gautgler MH, et al. Administration of recombinant human interleukin-11 after supralethal radiation exposure promotes survival in mice:interactive effect with thrombopoietin[J]. Radiat Res, 2002, 157(6):642-649.
[5] Farese AM, Hunt P, Grab LB, et al. Combined administration of recombinant human megakaryocyte growth factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia[J]. J Clin Invest, 1996, 97(9):2145-2151.
[6] Karen KJ, Dubbelman YD, Luo QL, et al. Simultaneous TPO and G-CSF treatment following cytoreductive treatment of rhesus monkeys prevents thrombocytpenia, accelerates platelet and red cell reconstitution, allevates neutropenia and promotes the recovery if immature bone marrow cells[J]. Exp Hematol, 1997, 25(10):1084.
[7] 郝静,罗庆良,熊国林,等.rhIL-11加rhG-CSF对8.0Gy照射猴的治疗作用[J].解放军医学杂志,2001,26(10):730-732.
[8] 邢爽,黄海潇,熊国林,等.重组人粒细胞集落刺激因子和重组人白介素11对3.5Gy照射狗的治疗作用[J].军事医学科学院院刊,2007,31(4):394-396.
[9] 赵杰,赵翔宇,黄晓军.白细胞介素11联合粒细胞集落刺激因子对小鼠异基因骨髓移植后移植物抗宿主病影响的研究[J].中华医学杂志,2005,85(35):2497-2502.
[10] Farese AM, Williams DE, Seiler FR, et al. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiationinduced marrow aplasia[J]. Blood, 1993, 82(10):3012-3018.
[11] 崔玉芳,杨红,罗庆良,等.rhIL-3和GM-CSF对γ线照射猴外周血淋巴细胞损伤的防护作用研究[J].中国危重病急救医学,2004,16(1):22-25.
[12] Drouet M, Mourcin F, Grenier N, et al. The effects of ionizing radiation on stem cells and hematopoietic progenitors:the place of apoptosis and the therapeutic potential of anti-apoptosis treatments[J]. Can J Physiol Pharmacol, 2002, 80(7):700-709.
[13] Hérodin F, Bourin P, Mayol JF, et al. Short term injection of antiapoptotic cytokine combinations soon after lethal gamma irradiation promotes survival[J]. Blood, 2003, 101(7):2609-2616.
[14] Droute M, Mourcin F, Grenier N, et al. Single administration of stem cell factor, Fit-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J]. Blood, 2004, 103(3):878-885.
[15] Hérodin F, Roy L, Grenier N, et al. Antiapoptotie eytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose[J]. Exp Hematol, 2007, 35(8):1172-1181.
[16] Hérodin F, Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches[J]. Exp Hematol, 2005, 33(10):1071-1080.
[17] Hérodin F, Grenier N, Drouet M. Revisting therapeutic strategies in radiation casuahies[J]. Exp Hematol, 2007, 35(4 suppl 1):28-33.
[18] Meineke V, Fliedner TM. Radiation-induced multi-organ involvement and failure:challenges for radiation accident medical management and future research[J]. BJR Suppl, 2005, 27:196-200.
[19] 邢爽,黄海潇,罗庆良.角质细胞生长因子对上皮细胞损伤的防护作用[J].国外医学药学分册,2006,33(2):97-99.
[20] Alpdogan O, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration[J]. Blood, 2006, 107(6):2453-2460.

相似文献/References:

[1]包明月,刘玉龙.应用间充质干细胞治疗急性辐射损伤的研究现状与进展[J].国际放射医学核医学杂志,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
 Bao Mingyue,Liu Yulong.Recent advances in the application of mesenchymal stem cells for treatment of acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
[2]贺欣,储小飞,罗丹,等.穿心莲药物对辐射损伤效应影响的初步研究[J].国际放射医学核医学杂志,2015,39(5):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
 he xin,chu xiaofei,luo dan,et al.exploration of andrographolide effects on radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
[3]路璐,张俊伶,李德冠,等.6 gy 137cs γ射线照射对小鼠造血功能损伤的动态观察研究[J].国际放射医学核医学杂志,2015,39(5):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
 lu lu*,zhang junling,li deguan,et al.effects of 6 gy 137cs γ-irradiattion on the hematopoietic system of mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
[4]刘惠惠,李险峰.放射性心脏损伤诊断和防治的临床研究进展[J].国际放射医学核医学杂志,2016,40(5):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
 Liu Huihui,Li Xianfeng.Clinical research progress in diagnosis,prevention and treatment of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
[5]张倩如,李海涛,田红旗.小分子辐射防护药物的研究进展[J].国际放射医学核医学杂志,2016,40(5):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
 Zhang Qianru,Li Haitao,Tian Hongqi.Small molecule compounds against radiation:research advances[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
[6]王浩,沈秀,靳瑾,等.“四物汤”对辐射危害的辅助保护作用研究[J].国际放射医学核医学杂志,2015,39(2):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
 Wang Hao,Shen Xiu,Jin Jin,et al.Protective activity of Siwu Decoction against radiation hazards[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
[7]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
 Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[8]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
 Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[9]李德冠,路璐,吴红英,等.G-CSF联合SB203580对4Gy照射小鼠免疫系统的作用[J].国际放射医学核医学杂志,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
 Li Deguan,Lu Lu,Wu Hongying,et al.The effects of G-CSF combined with SB203580 on the immune system of mice received 4 Gy total body irradiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
[10]张洪明,李险峰.放射性心脏损伤动物模型的研究进展[J].国际放射医学核医学杂志,2014,38(6):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
 Zhang Hong-ming,Li Xian-feng.Progress in animal model of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
[11]闵锐.辐射损伤防护药及细胞因子治疗研究动态[J].国际放射医学核医学杂志,2004,28(4):173.
 MIN Rui.Status of the research on radioprotective drugs and treatment of radiation damage by cytokines[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(1):173.

备注/Memo

备注/Memo:
收稿日期:2007-10-09。
基金项目:"十一五"全军医药卫生科研项目(062064)
通讯作者:罗庆良,E-mail:luoqingliang52@yahoo.com.cn
更新日期/Last Update: 1900-01-01